Mock-up Updates Study Tags (field_study_tags) - Any - ADEQUATE BE READY NOW Blog Call-outs CLIN-Net CoMeCT COVID-19 Data Ecraid ECRAID-Base Education EPI-Net EPOXI Interview Mpox NeoDeco NOFLU Partners People PIPELINE POS-ARI-ER POS-ARI-PC POS-cUTI POS-Disease X POS-VAP Primary Care PrIMAVeRA PRUDENCE RECLAIM RECOVERY REMAP-CAP SNAP SOS Covid STRIDE-CAP Training Vaccines 9.12.2025 A Lookback At The “Better Methods’” Postgraduate Course 2025 The fourth 'Better methods for clinical studies in infectious diseases and clinical microbiology' took place in Athens, Greece. 8.12.2025 Ecraid Joins the PrIMAVeRa Consortium to Accelerate Antimicrobial Resistance Modelling Ecraid has joined the PrIMAVeRa consortium, contributing extensive patient data to refine mathematical models for combating AMR. 25.11.2025 Introducing Ecraid's Young Investigator Ambassadors Representing the voices and perspectives of the next generation of scientists. 19.11.2025 From Europe to the World: Insights from Peter Horby An interview with Peter Horby about Ecraid’s unique clinical trial infrastructure, and the opportunities and challenges ahead. … 13.11.2025 Benefits of group sequential design and sample size re-estimation for randomised controlled trials evaluating the prevention of ventilator-associated pneumonia: a simulation study informed by real world data 12.11.2025 Lennie Derde Appointed New Ecraid Chief Executive Officer Ecraid is pleased to announce the appointment of Lennie Derde as its new Chief Executive Officer. Load More
9.12.2025 A Lookback At The “Better Methods’” Postgraduate Course 2025 The fourth 'Better methods for clinical studies in infectious diseases and clinical microbiology' took place in Athens, Greece.
8.12.2025 Ecraid Joins the PrIMAVeRa Consortium to Accelerate Antimicrobial Resistance Modelling Ecraid has joined the PrIMAVeRa consortium, contributing extensive patient data to refine mathematical models for combating AMR.
25.11.2025 Introducing Ecraid's Young Investigator Ambassadors Representing the voices and perspectives of the next generation of scientists.
19.11.2025 From Europe to the World: Insights from Peter Horby An interview with Peter Horby about Ecraid’s unique clinical trial infrastructure, and the opportunities and challenges ahead. …
13.11.2025 Benefits of group sequential design and sample size re-estimation for randomised controlled trials evaluating the prevention of ventilator-associated pneumonia: a simulation study informed by real world data
12.11.2025 Lennie Derde Appointed New Ecraid Chief Executive Officer Ecraid is pleased to announce the appointment of Lennie Derde as its new Chief Executive Officer.
